Expert Pitch
University of Notre Dame

In Rare Speech on Coronavirus, Queen Elizabeth Provides Calming Voice, Notre Dame Expert Says

6-Apr-2020 12:05 PM EDT, by University of Notre Dame

Queen Elizabeth delivered a rare, televised message April 5 urging self-discipline and resolve in the midst of the coronavirus pandemic and thanking health workers on the front lines of the crisis. She provided a “rational, calming” voice according to a University of Notre Dame communications expert.

"I am speaking to you at what I know is an increasingly challenging time,” the queen said. “A time of disruption in the life of our country: a disruption that has brought grief to some, financial difficulties to many, and enormous changes to the daily lives of us all.”

“While we have faced challenges before, this one is different,” she said. “This time we join with all nations across the globe in a common endeavor, using the great advances of science and our instinctive compassion to heal. We will succeed — and that success will belong to every one of us.”

Apart from her annual Christmas message, the queen has made only a handful of special broadcasts at critical moments of her 68-year-reign. She took to the airwaves during the Gulf War, following the death of Princess Diana, and following the death of her mother. This particular message came not a moment too soon, according to rhetorician James S. O’Rourke, professor of management at Notre Dame’s Mendoza College of Business.

“The queen did precisely what I thought she would,” O’Rourke said. “Somehow, no matter what the occasion, she always seems to know exactly what to say, and once again, her remarks were spot-on. She provides a far more rational, calming voice than her prime minister, Boris Johnson, minister for the cabinet office Michael Gove or others in her government whose sole focus of late has been telling the rest of Europe to go away.” 

“The queen did observe one primary rule of public speaking: the value of brevity,” O’Rourke said. “This was more than just encouragement, though, it was direction to the people of Britain from their head of state. And, in many ways, recordings of this speech will serve as an instructive tool to students of public speaking for a number of years.”

"I hope in the years to come, everyone will be able to take pride in how they responded to this challenge," the queen said, "and those who come after us will say that the Britons of this generation were as strong as any."

The U.K. is now on “soft lockdown” as Prime Minister Johnson has contracted coronavirus, along with the Prince of Wales and nearly 50,000 citizens.

“Britons have not faced such grim circumstances since the darkest days of World War II,” O’Rourke said. “Now, more than ever, the people of the UK must have someone to rely upon – someone whose word they can trust and who will both reassure them and tell them the truth. No one other than the Queen quite fits that description just now. This was precisely the right moment for Elizabeth to reassure Britons and the world that we’re in this together, and together we shall get through this.”

Elizabeth II is the longest-reigning monarch in the world. At age 93, she continues her duties and appears strong as ever. Palace insiders acknowledge that she writes her own speeches and prepares her own remarks.

“Queen Elizabeth is, without question, a remarkable woman who has served her people well,” O’Rourke said. “Even my Irish-American classmates from Notre Dame now acknowledge the value she’s delivered, not just to the U.K. but to the world."

Filters close

Showing results

110 of 2539
Released: 13-Jul-2020 4:05 PM EDT
OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available
Organization for Associate Degree Nursing (OADN)

OADN & AACN Secure No-Cost Access to COVID-19 Screening Solution Until Vaccines Become Widely Available

Newswise: Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Released: 13-Jul-2020 3:45 PM EDT
Study suggests lymphoma drug acalabrutinib might offer a potential therapeutic approach for severe COVID-19 infection
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.

Released: 13-Jul-2020 3:05 PM EDT
Asymptomatic Transmission and Reinfection of COVID: Live Event for July 16, 2PM EDT

Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.

Released: 13-Jul-2020 2:40 PM EDT
Engineered llama antibodies neutralize COVID-19 virus
Rosalind Franklin Institute

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

Released: 13-Jul-2020 12:25 PM EDT
Scientists discover key element of strong antibody response to COVID-19
Scripps Research Institute

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 13-Jul-2020 11:15 AM EDT
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes
University of Texas Health Science Center at Houston

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann and Harris Health System’s Lyndon B. Johnson Hospital.

Showing results

110 of 2539